New tool can help researchers to better understand the metabolism of microorganisms

Continued treatment with the osteoporosis drug denosumab (Prolia) was tied to a lower risk of developing diabetes in a Taiwanese cohort study. In a propensity

The De­part­ment of De­fense will pay up to $74 mil­lion to Evotec’s Seat­tle-based sub­sidiary to de­vel­op new an­ti­body treat­ments for or­thopoxvirus­es — a cat­e­go­ry of